Can we get antibiotics right for kids on ECMO?
NCT ID NCT06426836
First seen Jan 16, 2026 · Last updated Jun 18, 2026 · Updated 19 times
Summary
This study looks at how antibiotics behave in the bodies of critically ill newborns, infants, and children who are on a heart-lung machine called ECMO. Researchers want to find out if current doses are high enough to fight infections without causing harm. The goal is to improve dosing guidelines for these vulnerable patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Queen Fabiola Children's University Hospital
RECRUITINGBrussels, Brussels Capital, 1020, Belgium
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Universitair hospital
RECRUITINGLeuven, 3000, Belgium
Contact Email: •••••@•••••
-
University Hospital
RECRUITINGGhent, 9000, Belgium
Contact Email: •••••@•••••
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.